Intrexon (NASDAQ:XON) and US Stem Cell (OTCMKTS:USRM) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations.
Volatility and Risk
Intrexon has a beta of 2.36, suggesting that its share price is 136% more volatile than the S&P 500. Comparatively, US Stem Cell has a beta of 5.02, suggesting that its share price is 402% more volatile than the S&P 500.
75.7% of Intrexon shares are owned by institutional investors. 44.0% of Intrexon shares are owned by insiders. Comparatively, 16.7% of US Stem Cell shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Intrexon and US Stem Cell, as reported by MarketBeat.
Intrexon currently has a consensus target price of $19.67, indicating a potential upside of 211.18%. Given Intrexons higher probable upside, analysts clearly believe Intrexon is more favorable than US Stem Cell.
Profitability
This table compares Intrexon and US Stem Cells net margins, return on equity and return on assets.
Earnings & Valuation
This table compares Intrexon and US Stem Cells revenue, earnings per share and valuation.
US Stem Cell has lower revenue, but higher earnings than Intrexon.
Summary
Intrexon beats US Stem Cell on 7 of the 11 factors compared between the two stocks.
About Intrexon
Intrexon Corporation operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components. Its technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing; and ActoBiotics and AdenoVerse technology platforms. The company also provides reproductive technologies and other genetic processes to cattle breeders and producers; biological insect control solutions; technologies for non-browning apple without the use of any flavor-altering chemical or antioxidant additives; commercial aquaculture products; genetic preservation and cloning technologies; genetically engineered swine for medical and genetic research; and artwork, children's toys, and novelty goods that are derived from living organisms or enabled by synthetic biology. It serves health, food, energy, environment, and consumer markets. Intrexon Corporation has collaboration and license agreements with ZIOPHARM Oncology, Inc.; Oragenics, Inc.; Fibrocell Science, Inc.; Genopaver, LLC; S & I Ophthalmic, LLC; OvaXon, LLC; Intrexon Energy Partners, LLC; Persea Bio, LLC; Ares Trading S.A.; Intrexon Energy Partners II, LLC; Intrexon T1D Partners, LLC; AquaBounty Technologies, Inc.; Thrive Agrobiotics, Inc.; Exotech Bio, Inc.; Relieve Genetics, Inc.; AD Skincare, Inc.; Genten Therapeutics, Inc.; and CRS Bio, Inc. The company was formerly known as Genomatix Ltd. and changed its name to Intrexon Corporation in 2005. Intrexon Corporation was founded in 1998 and is based in Germantown, Maryland.
About US Stem Cell
U.S. Stem Cell, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of autologous cellular therapies for the treatment of chronic and acute heart damage, and vascular and autoimmune diseases in the United States and internationally. Its lead product candidates include MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells or cells from a patient's body for enhancing cardiac function in chronic heart failure patients; and AdipoCell, a patient-derived cell therapy for the treatment of acute myocardial infarction, chronic heart ischemia, and lower limb ischemia. The company's product development pipeline includes MyoCell SDF-1, an autologous muscle-derived cellular therapy for improving cardiac function in chronic heart failure patients. It is also developing MyoCath, a deflecting tip needle injection catheter that is used to inject cells into cardiac tissue in therapeutic procedures to treat chronic heart ischemia and congestive heart failure. In addition, the company provides physician and patient based regenerative medicine/cell therapy training, cell collection, and cell storage services; and cell collection and treatment kits for humans and animals, as well operates a cell therapy clinic. The company was formerly known as Bioheart, Inc. and changed its name to U.S. Stem Cell, Inc. in October 2015. U.S. Stem Cell, Inc. was founded in 1999 and is headquartered in Sunrise, Florida.
Receive News & Ratings for Intrexon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon and related companies with MarketBeat.com's FREE daily email newsletter.
Go here to see the original:
Reviewing Intrexon (NASDAQ:XON) & US Stem Cell (NASDAQ:USRM) - Mayfield Recorder
- Stem.MD | Stem Cell Therapy - Stem.MD [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- Maryland Stem Cell Research Fund - MDBIZNews [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- Capitol Pain Institute Celebrating Three Employee Anniversaries and the Addition of Ten Medical Assistants [Last Updated On: September 12th, 2014] [Originally Added On: September 12th, 2014]
- Turmeric Shows Benefit for 530 Health Conditions And Studied for Alzheimer's, Osteo and Rheumatoid Arthritis ... [Last Updated On: September 16th, 2014] [Originally Added On: September 16th, 2014]
- Why the eye is nature's miracle [Last Updated On: October 1st, 2014] [Originally Added On: October 1st, 2014]
- Under the lid - the mysteries of the eye are being unveiled [Last Updated On: October 13th, 2014] [Originally Added On: October 13th, 2014]
- UCSD Stem Cell program begins human testing [Last Updated On: October 21st, 2014] [Originally Added On: October 21st, 2014]
- stem cell - MDBIZNews - MDBIZNews - News of the growing ... [Last Updated On: October 23rd, 2014] [Originally Added On: October 23rd, 2014]
- MD Stem Cells Begins the Largest Stem Cell Eye Treatment ... [Last Updated On: November 5th, 2014] [Originally Added On: November 5th, 2014]
- Head, National Institutes of Health Stem Cell Technology ... [Last Updated On: November 11th, 2014] [Originally Added On: November 11th, 2014]
- Bid on Stem Cells and Alcohol-induced Tissue Injuries (R21 ... [Last Updated On: November 12th, 2014] [Originally Added On: November 12th, 2014]
- Toughest Breast Cancer May Have Met Its Match [Last Updated On: December 9th, 2014] [Originally Added On: December 9th, 2014]
- American Spine offers experimental fix for pain -- Gazette.Net [Last Updated On: January 28th, 2015] [Originally Added On: January 28th, 2015]
- American Spine offers experimental fix for pain [Last Updated On: January 28th, 2015] [Originally Added On: January 28th, 2015]
- Gene regulatory path revealed as target for therapy of aggressive pediatric brain cancer [Last Updated On: March 10th, 2015] [Originally Added On: March 10th, 2015]
- TiGenix: TiGenix reports its full year 2014 results [Last Updated On: March 18th, 2015] [Originally Added On: March 18th, 2015]
- MD Stem Cells Release Optic Nerve Vision Loss Reversed ... [Last Updated On: March 22nd, 2015] [Originally Added On: March 22nd, 2015]
- MRI based on a sugar molecule can tell cancerous from noncancerous cells [Last Updated On: March 27th, 2015] [Originally Added On: March 27th, 2015]
- Maryland Stem Cell Research Fund: Funding Opportunities [Last Updated On: July 2nd, 2015] [Originally Added On: July 2nd, 2015]
- Patients' Own Genetically Altered Immune Cells Show ... [Last Updated On: October 19th, 2015] [Originally Added On: October 19th, 2015]
- Human Stem Cells Institute - Wikipedia, the free encyclopedia [Last Updated On: October 19th, 2015] [Originally Added On: October 19th, 2015]
- Maryland Stem Cell Center Consortium and Core Facility ... [Last Updated On: August 12th, 2016] [Originally Added On: August 12th, 2016]
- Human Induced Pluripotent Stem Cell Derived Neuronal Cells ... [Last Updated On: August 18th, 2016] [Originally Added On: August 18th, 2016]
- Johns Hopkins Team Creates Stem Cells From Schizophrenia ... [Last Updated On: September 5th, 2016] [Originally Added On: September 5th, 2016]
- Ginger | University of Maryland Medical Center [Last Updated On: September 6th, 2016] [Originally Added On: September 6th, 2016]
- Center for Stem Cell Biology & Regenerative Medicine ... [Last Updated On: November 14th, 2016] [Originally Added On: November 14th, 2016]
- The Maryland Stem Cell Research Fund (MSCRF) | Tedco [Last Updated On: November 25th, 2016] [Originally Added On: November 25th, 2016]
- Roanoke researchers pursue treatments for the type of deadly brain cancer affecting McCain - Roanoke Times [Last Updated On: August 3rd, 2017] [Originally Added On: August 3rd, 2017]
- Cannon Scholars visit National Institute of Standards and Technology - Dover Post [Last Updated On: August 9th, 2017] [Originally Added On: August 9th, 2017]
- Lab-Grown, Virus-Free Stem Cells Repair Retinal Tissue in ... [Last Updated On: August 9th, 2017] [Originally Added On: August 9th, 2017]
- Science and technology to get boost from CRS-12 mission - SpaceFlight Insider [Last Updated On: August 12th, 2017] [Originally Added On: August 12th, 2017]
- How Stem Cell Therapy Can Help Repair and ... - Mercola.com [Last Updated On: September 4th, 2017] [Originally Added On: September 4th, 2017]
- How Stem Cell Therapy Can Help Repair and Regenerate Your Body [Last Updated On: October 12th, 2017] [Originally Added On: October 12th, 2017]
- Free stem cell Essays and Papers - 123HelpMe [Last Updated On: October 12th, 2017] [Originally Added On: October 12th, 2017]
- Catholic response to stem cells - Featured Today ... [Last Updated On: October 14th, 2017] [Originally Added On: October 14th, 2017]
- Excellence in Stem Cell Research | University of Maryland ... [Last Updated On: June 24th, 2018] [Originally Added On: June 24th, 2018]
- Maryland Stem Cell Research Fund: 2014 Awardees [Last Updated On: June 24th, 2018] [Originally Added On: June 24th, 2018]
- Nervous System Stem Cells Can Replace Themselves, Give ... [Last Updated On: July 3rd, 2018] [Originally Added On: July 3rd, 2018]
- Baltimore, Maryland Stem Cell Transplants, Montgomery ... [Last Updated On: August 17th, 2018] [Originally Added On: August 17th, 2018]
- Stem Cell Clinical Trial | University of Maryland Children ... [Last Updated On: August 17th, 2018] [Originally Added On: August 17th, 2018]
- STEM CELL THERAPY - Orthopedic and Wellness Maryland [Last Updated On: September 5th, 2018] [Originally Added On: September 5th, 2018]
- Patient Resources | University of Maryland School of Medicine [Last Updated On: September 5th, 2018] [Originally Added On: September 5th, 2018]
- Stem Cell Centers - Towson > Stem Cell Centers [Last Updated On: October 6th, 2018] [Originally Added On: October 6th, 2018]
- Stem Cell Therapy in Annapolis Maryland | Stem Cell ... [Last Updated On: October 25th, 2018] [Originally Added On: October 25th, 2018]
- Meristem - Wikipedia [Last Updated On: January 17th, 2019] [Originally Added On: January 17th, 2019]
- Stem Cell Therapy in Maryland | Stem Cell Professionals [Last Updated On: April 5th, 2019] [Originally Added On: April 5th, 2019]
- Stem Cells and Type 1 Diabetes: What the Future Has in ... [Last Updated On: April 24th, 2019] [Originally Added On: April 24th, 2019]
- cord_blood - Maryland [Last Updated On: September 14th, 2019] [Originally Added On: September 14th, 2019]
- Artificially Engineering Intestine - Mirage News [Last Updated On: September 25th, 2019] [Originally Added On: September 25th, 2019]
- Prothena Corporation plc (PRTA)'s Financial Results Comparing With Neuralstem Inc. (NASDAQ:CUR) - The EN Herald [Last Updated On: September 25th, 2019] [Originally Added On: September 25th, 2019]
- Analyzing US Stem Cell (OTCMKTS:USRM) and Intrexon (OTCMKTS:XON) - TechNewsObserver [Last Updated On: September 25th, 2019] [Originally Added On: September 25th, 2019]
- Head-To-Head Survey: Intrexon (NASDAQ:XON) versus US Stem Cell (NASDAQ:USRM) - Riverton Roll [Last Updated On: September 25th, 2019] [Originally Added On: September 25th, 2019]
- Comparing of Neuralstem Inc. (CUR) and Allakos Inc. (NASDAQ:ALLK) - MS Wkly [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Contrasting of Applied Therapeutics Inc. (APLT) and Neuralstem Inc. (NASDAQ:CUR) - MS Wkly [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Reviewing Synthetic Biologics Inc. (SYN)'s and Asterias Biotherapeutics Inc. (:)'s results - FinanceMercury [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- BioLineRx Presents Preclinical Data From Triple Combination of BL-8040, Anti PD-1 and Chemotherapy Demonstrating Significant Reduction in Pancreatic... [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- VetStem Biopharma Shares the Success Story of Ole who was Treated with VetStem Cell Therapy by Dr. Holly Mullen - PR Web [Last Updated On: November 6th, 2019] [Originally Added On: November 6th, 2019]
- Serving those who serve - The Hub at Johns Hopkins [Last Updated On: November 14th, 2019] [Originally Added On: November 14th, 2019]
- Organoids, iPSCs, and advanced cell models: Advancing discovery from basic research to drug discovery - Science Magazine [Last Updated On: March 4th, 2020] [Originally Added On: March 4th, 2020]
- Maryland Stem Cell Center Consortium & Core Facility ... [Last Updated On: March 4th, 2020] [Originally Added On: March 4th, 2020]
- Dr Borehams Crucible: The small cap biotechs trying to make a buck from coronavirus - Stockhead [Last Updated On: March 9th, 2020] [Originally Added On: March 9th, 2020]
- The Aussie Biotech Companies Trying To Make A Buck From Coronavirus - D'Marge [Last Updated On: March 9th, 2020] [Originally Added On: March 9th, 2020]
- Watch: Hogan orders closure of bars, restaurants, theaters and gyms, restricts gatherings - Maryland Daily Record [Last Updated On: March 22nd, 2020] [Originally Added On: March 22nd, 2020]
- Could Innate Immunology Save Us From the Coronavirus? - The New York Times [Last Updated On: May 3rd, 2020] [Originally Added On: May 3rd, 2020]
- David C. Karli is Offering a New Ray of Hope Through Regenerative Medicine - RESPECT. [Last Updated On: May 3rd, 2020] [Originally Added On: May 3rd, 2020]
- What Do New Neurons in the Brains of Adults Actually Do? - The Scientist [Last Updated On: May 7th, 2020] [Originally Added On: May 7th, 2020]
- 'Virus Goes In, Virus Goes Out': Advocates Call For Release Of More Low-Level Prisoners To Stem Infection Rate - Kaiser Health News [Last Updated On: May 22nd, 2020] [Originally Added On: May 22nd, 2020]
- Researchers develop nanoengineered bioink to 3D print functional bone tissue - 3D Printing Industry [Last Updated On: May 27th, 2020] [Originally Added On: May 27th, 2020]
- Over $8M in 2020 Stem Cell Funding Awards Continue to Fuel Marylands Leading Cell Therapy Industry - BioBuzz [Last Updated On: June 24th, 2020] [Originally Added On: June 24th, 2020]
- CRISPR cows could boost sustainable meat production, but regulations and wary consumers stand in the way - Genetic Literacy Project [Last Updated On: August 26th, 2020] [Originally Added On: August 26th, 2020]
- ShoreRivers awarded DNR grant for two restoration projects - MyEasternShoreMD [Last Updated On: August 26th, 2020] [Originally Added On: August 26th, 2020]
- New toilet, a VR camera and science experiments are heading to t - KAKE [Last Updated On: October 8th, 2020] [Originally Added On: October 8th, 2020]
- Trump was one of the first 10 patients to get an experimental COVID-19 treatment under special use - Yahoo News [Last Updated On: October 8th, 2020] [Originally Added On: October 8th, 2020]
- Sirnaomics to Initiate Phase I Study of STP705 in Treatment of Primary and Metastatic Liver Cancer | DNA RNA and Cells | News Channels -... [Last Updated On: December 7th, 2020] [Originally Added On: December 7th, 2020]
- US gets more help in raging battle against COVID-19 as FDA authorizes Moderna vaccine, the second allowed for emergency use - USA TODAY [Last Updated On: December 20th, 2020] [Originally Added On: December 20th, 2020]
- UMD Researchers Perform Crucial Proof-of-Concept ... [Last Updated On: December 20th, 2020] [Originally Added On: December 20th, 2020]
- What really happened in Wuhan? - The Sunday Guardian Live - The Sunday Guardian [Last Updated On: June 6th, 2021] [Originally Added On: June 6th, 2021]
- A Look Inside A Termite's Gut Wins The 11th Annual Nikon Small World in Motion Competition - PRNewswire [Last Updated On: August 18th, 2021] [Originally Added On: August 18th, 2021]
- US is Out of Step on Primate Research With Rest of World - NewsClick [Last Updated On: October 5th, 2021] [Originally Added On: October 5th, 2021]
- Synthetic biology's past, present and future explored in timely new account - Winnipeg Free Press [Last Updated On: April 6th, 2022] [Originally Added On: April 6th, 2022]